AMG National Trust Bank Has $993,000 Position in Colgate-Palmolive (NYSE:CL)

AMG National Trust Bank decreased its holdings in shares of Colgate-Palmolive (NYSE:CL) by 68.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 9,563 shares of the company’s stock after selling 20,633 shares during the quarter. AMG National Trust Bank’s holdings in Colgate-Palmolive were worth $993,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CL. E Fund Management Hong Kong Co. Ltd. bought a new position in shares of Colgate-Palmolive during the 2nd quarter worth approximately $25,000. Continuum Advisory LLC lifted its holdings in shares of Colgate-Palmolive by 46.5% during the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after acquiring an additional 125 shares during the period. Reston Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at $42,000. Capital Performance Advisors LLP bought a new stake in shares of Colgate-Palmolive in the 3rd quarter worth about $53,000. Finally, Gradient Investments LLC increased its position in shares of Colgate-Palmolive by 150.4% during the 2nd quarter. Gradient Investments LLC now owns 666 shares of the company’s stock worth $65,000 after purchasing an additional 400 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Down 1.1 %

Colgate-Palmolive stock opened at $93.61 on Wednesday. The firm has a market capitalization of $76.48 billion, a price-to-earnings ratio of 26.82, a PEG ratio of 3.34 and a beta of 0.42. The company’s 50 day simple moving average is $98.80 and its 200 day simple moving average is $98.56. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. Colgate-Palmolive has a fifty-two week low of $75.17 and a fifty-two week high of $109.30.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.14%. The ex-dividend date of this dividend was Friday, October 18th. Colgate-Palmolive’s dividend payout ratio (DPR) is 57.31%.

Analyst Upgrades and Downgrades

Several analysts have weighed in on CL shares. HSBC reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research note on Friday, July 26th. Wells Fargo & Company decreased their price target on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a research report on Monday, October 28th. JPMorgan Chase & Co. lifted their price objective on Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Piper Sandler began coverage on Colgate-Palmolive in a report on Tuesday, September 24th. They set an “overweight” rating and a $121.00 target price on the stock. Finally, UBS Group raised their target price on Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, Colgate-Palmolive presently has an average rating of “Moderate Buy” and a consensus price target of $105.11.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the transaction, the director now owns 11,755 shares of the company’s stock, valued at $1,220,874.30. This trade represents a 16.44 % decrease in their position. The disclosure for this sale can be found here. 0.37% of the stock is owned by corporate insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.